tiprankstipranks
CERE Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCERE Upcoming Earnings Report: What to Expect?
4M ago
Cerevel Therapeutics Advances in Merger Amid FTC Review
PremiumCompany Announcements
Cerevel Therapeutics Advances in Merger Amid FTC Review
5M ago
Cerevel Therapeutics price target raised to $45 from $25 at Mizuho
PremiumThe Fly
Cerevel Therapeutics price target raised to $45 from $25 at Mizuho
5M ago
Reviva may be most undervalued in neurology, says H.C. Wainwright
PremiumThe FlyReviva may be most undervalued in neurology, says H.C. Wainwright
7M ago
Cerevel Therapeutics price target raised to $45 from $30 at Wells Fargo
PremiumThe Fly
Cerevel Therapeutics price target raised to $45 from $30 at Wells Fargo
7M ago
Cerevel Therapeutics downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Cerevel Therapeutics downgraded to Hold from Buy at Jefferies
7M ago
Cerevel Therapeutics to host conference call
PremiumThe FlyCerevel Therapeutics to host conference call
7M ago
Cerevel Therapeutics to host conference call
PremiumThe Fly
Cerevel Therapeutics to host conference call
7M ago
Cerevel Therapeutics just downgraded at TD Cowen, here’s why
PremiumThe Fly
Cerevel Therapeutics just downgraded at TD Cowen, here’s why
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100